Organisation paid for research Program year 2025 Source: CMS Open Payments

Affinity Cardiovascular Specialists

Neither a doctor nor a teaching hospital

Research payments

$126,969

42 payments

Through program year 2025, Affinity Cardiovascular Specialists is reported as receiving $126,969 in research payments, across 42 payments.

By program year

7 rows
Year Kind Amount Payments
2025 Research $10,313 9
2024 Research $43,223 6
2023 Research $765 2
2022 Research $3,517 5
2021 Research $13,878 5
2020 Research $33,876 10
2019 Research $21,397 5

Breakdown

Who paid Research payments · program years 2019–2025
  1. Abbott Laboratories $116,656 33 payments
  2. Biosense Webster, Inc. $10,313 9 payments
Studies the money was for Research payments · program years 2019–2025
  1. VOLT-AF IDE Clinical Study $42,223 4 payments
  2. Safety and Effectiveness of TactiCath Contact Force, Sensor Enabled (TactiCath SE) Catheter for Ablation of Drug Refractory, Symptomatic, Persistent Atrial Fibrillation (PERSIST-END IDE) $21,346 6 payments
  3. FLExAbility Sensor Enabled Substrate Targeted Ablation for the Reduction of Ventricular Tachycardia (LESS-VT) Study $12,530 4 payments
  4. Safety and Effectiveness of TactiCath Contact Force, Sensor Enabled (TactiCath SE) Catheter for Ablation of Drug Refractory, Symptomatic, Persistent Atrial Fibrillation (PERSIST-END Trial) $12,453 2 payments
  5. Safety and Effectiveness of TactiCath Contact Force, Sensor Enabled (TactiCath SE) Catheter for Ablation of Drug Refractory, Symptomatic, Persistent Atrial Fibrillation (PERSIST-END Trial) $12,285 1 payment
  6. Safety and Effectiveness Evaluation of the THERMOCOOL SMARTTOUCH(TM) SF Catheter with the TRUPULSE(TM) Generator for treatment of the Paroxysmal Atrial Fibrillation $9,563 8 payments
  7. PERSIST-END Trial $5,862 2 payments
  8. Safety and Effectiveness of TactiCath Contact Force, Sensor Enabled (TactiCath SE) Catheter for Ablation of Drug Refractory, Symptomatic, Persistent Atrial Fibrillation (PERSIST-END IDE) $3,417 4 payments
  9. Less-Vt $3,000 1 payment
  10. FLExAbility Sensor Enabled Substrate Targeted Ablation for the Reduction of VT $1,425 3 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record